VR Logo

Applied Molecular Transport Inc. (AMTI) download report


Healthcare | Biotechnology & Pharma Research

Applied Molecular Transport Inc. (AMTI) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases.

IPO Date: 05-Jun-2020

Exec. Chairman: Mr. Graham K. Cooper

Co-Founder, CEO & Director: Dr. Tahir Mahmood Ph.D.

Listing: NASDAQ: AMTI

Country: United States

Headquarters: South San Francisco, CA

Website: https://www.appliedmt.com

Key Facts

Market cap: $112.10 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-122.40 Mln

Cash: $126.48 Mln

Total Debt: $39.51 Mln

Insider's Holding: 23.09%

Liquidity: Low

52 Week range: $2.67 - 47.00

Shares outstanding: 38,654,200

Stock Performance

Time Period Applied Molecular Transport (AMTI) S&P BSE Sensex* S&P Small-Cap 600*
YTD-79.26-8.62-18.78
1 month-12.91-4.54-8.00
3 months-61.44-10.19-13.65
1 Year-93.661.43-17.19
3 Years--10.146.10
5 Years--11.265.87
10 Years--11.829.84
As on 01-Jul-2022 *As on 04-Jul-2022
Year Applied Molecular Transport (AMTI) S&P Small-Cap 600 S&P BSE Sensex
2021-54.5725.2721.99